Need to Know: How a massive ship, a behemoth plane and a glass staircase captured our attention

I'm Rob, and I'm your guide through a more casual look at the Business Journal's week that was — and what will be. If you missed Friday’s cover story, Ashley Stewart took readers inside the EB-5 investor program and how developers are using a program m...

By | 2019-04-21T14:09:20+00:00 April 21st, 2019|Healthcare|

Tampa health care technology service acquires Jacksonville company

HealthAxis Group, a Tampa-based health technology service, has acquired a Jacksonville firm that develops and implements data warehouse and business intelligence solutions. Terms of the acquisition of Analytics Partners were not disclosed. The merge...

By | 2019-04-19T17:37:18+00:00 April 19th, 2019|Healthcare|

Supreme Court to hear consent-decree arguments May 16

The Supreme Court of Pennsylvania will hear Attorney General Josh Shapiro’s appeal to extend the UPMC-Highmark consent decree on Thursday, May 16. Earlier this week, the Supreme Court had allowed Shapiro to appeal the Supreme Court’s 2018 ruling on th...

By | 2019-04-19T17:06:25+00:00 April 19th, 2019|Healthcare|

Gilead teams with startup to turn machine learning on fatty liver disease

Even before much of the world last year found out about Daphne Koller's machine-learning-driven drug development company, she was invited to speak to Gilead Sciences Inc. scientists. The ensuing conversations have led Koller's Insitro to formally work ...

By | 2019-04-16T13:51:46+00:00 April 16th, 2019|Healthcare|

Startup with South Florida ties raises $10M from former Publix CEO’s firm

Health-tech startup Bridge Connector has raised a new $10 million round of funding, bringing the total amount raised by the 13-month-old company to $20 million, according to a news release. Bridge Connector moved its headquarters to Nashville, Tenness...

By | 2019-04-16T13:40:46+00:00 April 16th, 2019|Healthcare|

Palvella Therapeutics raises $3M to advance rare disease drug

Palvella Therapeutics, a Wayne-based biopharmaceutical company developing treatments for rare disease, has raised $3.4 million in an equity financing deal. The private stock sale was disclosed in documents the company filed with the Securities and Exc...

By | 2019-04-15T10:40:39+00:00 April 15th, 2019|Healthcare|